Sera Prognostics, Inc.
NASDAQ:SERAMedical - Diagnostics & Research
-$0.03 today
- Market cap
- $74.11M
- Beta
- 0.94
- P/E (TTM)
- -2.9
- EPS (TTM)
- -$0.64
Volume 0.01M
Average 0.06M
SERA Total Liabilities
Everything the company owes to creditors and other parties.
Sera Prognostics, Inc.NASDAQ: SERA
Total Liabilities · Q1 FY2026 · quarter ended Mar 2026
Total liabilities rises 10.8% from a year ago
Total liabilities stood at $25.92M at the end of Q1 FY2026, up 10.8% from a year earlier and down 2.3% from the prior quarter. Over 3 fiscal years it compounded at +15.1% a year.
Context
- Total liabilities amounted to 27.7% of total assets at the end of Q1 FY2026, up 7.9 pp from a year earlier.
- Total liabilities increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total liabilities keeps rising in the next quarterly balance sheet after a +10.8% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 26.53M USD
- Year-over-year change
- +7.1%
- 4-year CAGR
- +33.0%
| Period | Period end | Total Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 26.53M | +7.1% |
| FY2024 | 2024-12-31 | 24.77M | -2.0% |
| FY2023 | 2023-12-31 | 25.28M | +45.4% |
| FY2022 | 2022-12-31 | 17.39M | +105.4% |
| FY2021 | 2021-12-31 | 8.47M | — |
Total Liabilities vs competitors
How SERA compares with its peers on the latest reported figures
- Peers report in different currencies, so total liabilities is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +10.8% is the 4th highest of 9, against a peer median of +0.7%.
- Total liabilities amounts to 27.7% of total assets for SERA, versus a peer median of 73.3%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $398.86M USD | +265.4% | +177.3% | 330.4% | |
| Mar 2026 | $49.94M USD | +0.9% | +54.9% | 79.2% | |
| Mar 2026 | $41.97M USD | +110.4% | +16.3% | 67.3% | |
| Mar 2026 | $30.08M USD | -21.2% | +46.1% | 88.3% | |
| Mar 2026 | $25.92M USD | +10.8% | +15.1% | 27.7% | |
| Mar 2026 | CA$13.29M CAD | +0.6% | +13.0% | 162.9% | |
| Mar 2026 | $6.51M USD | +36.2% | +30.4% | 21.9% | |
| Mar 2026 | $6.23M USD | -44.5% | +11.5% | 17.2% | |
| Mar 2026 | $2.22M USD | -74.7% | +28.8% | 1.2% | |
| Peer median (excluding SERA) | — | +0.7% | +29.6% | 73.3% | |
Competitors are the stored peer set for SERA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 58.93M | 29.88M | 3.88M | 4.04M | 3.94M |
| Short-term Investments | 46.18M | 52.83M | 45.2M | 42.19M | 35.26M |
| Net Receivables | 3.14M | 6.11M | 11.47M | 34K | 12K |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 1.99M | 1.31M | 795K | 19K | 1.56M |
| Total Current Assets | 110.25M | 90.13M | 61.34M | 47.6M | 40.77M |
| Property, Plant & Equipment (Net) | 1.77M | 3.06M | 3.18M | 1.85M | 3.55M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 1.03M | 910K |
| Long-term Investments | 34.85M | 21.33M | 30.84M | 21.97M | 56.58M |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 157K | 1.82M | 77K | 124K | 123K |
| Total Non-current Assets | 36.78M | 26.2M | 34.1M | 24.98M | 61.16M |
| Total Assets | 147.03M | 116.33M | 95.44M | 72.58M | 101.93M |
| Account Payables | 1.2M | 1.55M | 1.05M | 1.97M | 862K |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 3.12M | 9.08M | 20.24M | 20.22M | 20.32M |
| Other Current Liabilities | 3.56M | 1.07M | 926K | 20.52M | 3.01M |
| Total Current Liabilities | 8.41M | 15.54M | 24.44M | 24.77M | 24.19M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Non-current Liabilities | 54K | 1.85M | 840K | 2K | 2.34M |
| Total Liabilities | 8.47M | 17.39M | 25.28M | 24.77M | 26.53M |
| Common Stock | 3K | 3K | 3K | 3K | 4K |
| Retained Earnings | (166.47M) | (210.65M) | (246.9M) | (279.79M) | (311.72M) |
| Accumulated OCI | (183K) | (981K) | (15K) | 60K | 262K |
| Other Stockholders Equity | 0 | 0 | 0 | (0) | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 138.56M | 98.94M | 70.16M | 47.8M | 75.41M |
| Total Debt | 128K | 2.83M | 1.86M | 840K | 2.34M |
| Net Debt | (58.8M) | (27.05M) | (2.02M) | (3.2M) | (1.61M) |
Sera Prognostics, Inc.
NASDAQ:SERA
Intrinsic Alpha fair value
Locked
Current Price
$1.91
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.